2024-11-18 - Analysis Report
## Merck & Co Inc (MRK) Stock Analysis Report

**1. Performance Relative to S&P 500 (VOO):**

Merck & Co Inc (MRK) is a leading pharmaceutical company.  The provided data shows a cumulative return of 63.29% for MRK, compared to 123.86% for the S&P 500 (VOO). This represents a significant underperformance of -60.57%. The relative underperformance, considering historical volatility, places MRK at the 6.38th percentile of its historical range of underperformance relative to the S&P 500.  The provided alpha and beta values fluctuate across the years suggesting varying levels of correlation with the market and risk-adjusted return. Note that CAGR (Compound Annual Growth Rate) varies greatly from year to year indicating inconsistent performance.

**2. Recent Price Movement:**

* **Closing Price:** $96.31
* **5-Day Moving Average:** $98.50
* **20-Day Moving Average:** $102.35
* **60-Day Moving Average:** $110.03

The stock price is currently below all three moving averages, suggesting a downtrend.

**3. Technical Indicators and Expected Return:**

* **RSI (Relative Strength Index):** 22.69 - This indicates the stock is in oversold territory, potentially suggesting a bounce.
* **PPO (Price Oscillator):** -0.31 -  A negative value suggests bearish momentum.
* **20-Day Relative Divergence:** -18.32 - This signifies a recent period of underperformance relative to the S&P 500.
* **Expected Return:** 0.0% - This suggests that, based on current data, there is no expected outperformance over the S&P 500 for long-term (2+ years) investment. This will depend greatly on future performance, of course.  The current price of $96.31, being below the moving averages, doesn't immediately suggest a dramatic rebound or drop; however, the low RSI suggests potential for a bounce.

**4. Recent Financials and Outlook:**

The provided EPS and revenue data shows some fluctuation. While revenue remains relatively consistent, EPS has shown some variability.  More detailed analysis, including comparisons to analyst estimates and industry benchmarks, would be necessary for a comprehensive assessment.  Missing is the expected EPS for the latest reported quarter.


**5. Quarterly Financial Data Analysis:**

* **Revenue and Profitability:** Revenue is generally stable. Profit margins are high but show a slight downward trend over the past year, though recent quarters show a recovery.
* **Capital and Profitability:** Equity shows a moderate growth trend. ROE (Return on Equity) is volatile, with significant swings between positive and negative values, suggesting periods of strong and weak profitability.

More detailed analysis is needed to assess the financial health and sustainability of the business.

**6. News and Recent Issues:**

*(This section requires access to real-time news sources such as Shacknews and Finbold.  Please provide current news articles for a thorough analysis.)*  A search for recent news (within the last 48 hours) would uncover any significant developments impacting MRK's stock price, including earnings reports, regulatory updates, or market sentiment shifts.  Analyst opinions will also be crucial to determine the range of expectations for future performance.

**7.  Overall Analysis:**

MRK is currently underperforming the S&P 500, exhibiting a bearish technical outlook (RSI, PPO, moving averages).  While the low RSI suggests potential for a short-term rebound, the long-term outlook remains uncertain, given the inconsistent performance indicated by the CAGR data and fluctuating ROE. A comprehensive assessment requires further research into the current news, analyst opinions, and a deeper dive into the company's financials, specifically comparing actual results to expected results (including the missing information for the most recent quarter).


**8. Disclaimer:**

This report is for informational purposes only and does not constitute financial advice.  Investing in the stock market involves risk, and you should conduct your own thorough research and consult with a financial advisor before making any investment decisions.  The analysis provided is based on the limited data provided and may not reflect all relevant factors.
